Resección local, resección radical y amputación abdominoperineal: Hartmann bajo versus amputación abdominoperineal interesfinteriana

Autores/as

  • JD Prieto González Complejo Hospitalario Universitario de Santiago. Área Sanitaria de Santiago de Compostela e Barbanza.
  • MI Torres García Complejo Hospitalario Universitario Lucus Augusti. Área Sanitaria de Lugo, A Mariña e Monforte de Lemos.
  • PJ Paredes Cotoré Complejo Hospitalario Universitario de Santiago. Área Sanitaria de Santiago de Compostela e Barbanza.

Palabras clave:

cáncer de recto

Resumen

Artículo especial: capítulo 4 de la “Guía práctica para el tratamiento quirúrgico del cáncer de recto" del Grupo Gallego de Coloproctología y la Sociedad de Cirugía de Galicia

Descargas

Los datos de descargas todavía no están disponibles.

Citas

86. Mellgren A., Sirivongs P., Rothenberger D. A., Madoff R. D., García Aguilar J. Is local excision adequate therapy for early rectal cancer? Dis Colon Rectum. 2000; 43:1064-71; discussion 1071-4. Doi: 10.1007/BF02236551.

87. Nascimbeni R., Burgart L. J., Nivatvongs S., Larson Dr. Risk of lymph node metastasis in T1 carcinoma of the colon and rectum. Dis Colon Rectum. 2002; 45:200-6. Doi: 10.1007/s10350-004-6147-7.

88. Serra Aracil X., Mora López L., Alcántara Moral M., Caro Tarrago A., Gómez Díaz C. J., Navarro Soto S. Transanal endoscopic surgery in rectal cancer. World J Gastroenterol. 2014; 20:11538-45. Doi: 10.3748/wjg.v20.i33.11538.

89. Heafner T. A., Glasgow S. C. A critical review of the role of local excision in the treatment of early (T1 and T2) rectal tumors. J Gastrointest Oncol. 2014; 5:345-52. Doi: 10.3978/j.issn.2078-6891.2014.066.

90. Balyasnikova S., Read J., Wotherspoon A., Rasheed S., Tekkis P., Tait D., Cunningham D., Brown G. Diagnostic accuracy of high-resolution MRI as a method to predict potentially safe endoscopic and surgical plans in patients with early rectal cancer. BMJ Open Gastroenterol. 2017; 4:e000151. Doi: 10.1136/bmjgast-2017-000151.

91. Smits L. J. H., van Lieshout A. S., Grüter A. A. J., Horsthuis K., Tuynman J. B. Multidisciplinary management of early rectal cancer - The role of surgical local excision in current and future clinical practice. Surg Oncol. 2022; 40:101687. Doi: 10.1016/j.suronc.2021.101687.

92. Althumairi A. A., Gearhart S. L. Local excision for early rectal cancer: transanal endoscopic microsurgery and beyond. J Gastrointest Oncol. 2015; 6:296-306. Doi: 10.3978/j.issn.2078-6891.2015.022. PMID: 26029457;

93. Jóns H. J. S., Cunningham C. Adjuvant radiotherapy after local excision of rectal cancer. Acta Oncol. 2019; 58(sup1):S60-S64. Doi: 10.1080/0284186X. 2019.1578895.

94. Le L., Edwards K., Hunter I. A., Hartley J. E., Atallah S. B., Albert M. R., Hill J., Monson J. R. Quality of Local Excision for Rectal Neoplasms Using Transanal Endoscopic Microsurgery Versus Transanal Minimally Invasive Surgery: A Multi-institutional Matched Analysis. Dis Colon Rectum. 2017; 60:928-35. Doi: 10.1097/DCR.0000000 000000884.

95. Stipa F., Tierno S. M., Russo G., Burza A. Trans-anal minimally invasive surgery (TAMIS) versus trans-anal endoscopic microsurgery (TEM): a comparative case-control matched-pairs analysis. Surg Endosc. 2022; 36:2081-86. Doi: 10.1007/s00464-021-08494-e.

96. Schwab M. E., Hernández S., Watanaskul S., Chern H., Varma M., Sarin A. Comparison of advanced techniques for local excision of rectal lesions: a case series. BMC Surg. 2022; 22:117. Doi: 10.1186/s12893-022-01543-w.

97. You Y. N., Baxter N. N., Stewart A., Nelson H. Is the increasing rate of local excision for stage I rectal cancer in the United States justified?: a nationwide cohort study from the National Cancer Database. Ann Surg. 2007; 245:726-33. Doi: 10.1097/01.sla.0000252590.95116.4f.

98. De Graaf E. J., Doornebosch P. G., Tollenaar R. A., Meershoek-Klein Kranenbarg E., de Boer A. C., Bekkering F. C., et al. Transanal endoscopic microsurgery versus total mesorectal excision of T1 rectal adenocarcinomas with curative intention. Eur J Surg Oncol. 2009; 35:1280-5. Doi: 10.1016/j.ejso.2009.05.001.

99. van Oostendorp S. E., Smits L. J. H., Vroom E., Detering R., Heymans M. W., Moons L. M. G., et al. Local recurrence after local excision of early rectal cancer: a meta-analysis of completion TME, adjuvant (chemo)radiation, or non additional treatment. Br. J. Surg. 2020; 107:1719-30. Doi: 10.1002/bjs.12040.

100. Russo S., Blackstock A. W., Herman J. M., Abdel Wahab M., Azad N., Das P., et al. ACR Appropriateness Criteria® Local Excision in Early Stage Rectal Cancer. Am J Clin Oncol. 2015; 38:520-5. Doi: 10.1097/COC.0000000000000197.

101. Rullier E., Vendrely V., Asselineau J., Rouanet P., Tuech J. J., Valverde A., et al. Organ preservation with chemoradiotherapy plus local excision for rectal cancer: 5-year results of the GRECCAR 2 randomised trial. Lancet Gastroenterol Hepatol. 2020; 5(5):465-474. Doi: 10.1016/S2468-1253(19)30410-8.

102. Peltrini R., Imperatore N., Di Nuzzo M. M., Pellino G. Towards personalized treatment of T2N0 rectal cancer: A systematic review of long-term oncological outcomes of neoadjuvant therapy followed by local excision. J Gastroenterol Hepatol. 2022; 37:1426-33. Doi: 10.1111/jgh.15898.

103. Quirke P., Steele R., Monson J., Grieve R., Khanna S., Couture J., et al. Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial. Lancet. 2009; 373:821-8. Doi: 10.1016/S0140-6736(09)60485-2.

104. Nagtegaal I. D., van de Velde C. J., van der Worp E., Kapiteijn E., Quirke P., van Krieken J. H.; Cooperative Clinical Investigators of the Dutch Colorectal Cancer Group. Macroscopic evaluation of rectal. 20:1729-34.doi: 10.1200/JCO.2002. 07.010.

105. Herzog, T., Belyaev, O., Chromik, A. Weyhe D., Mueller C. A., Munding J., et al. TME quality in rectal cancer surgery. Eur J Med Res 2010; 15, 292. https://doi.org/10.1186/2047-783X-15-7-292.

106. Maslekar S., Sharma A., Macdonald A., Gunn J., Monson J. R., Hartley J. E. Mesorectal grades predict recurrences after curative resection for rectal cancer. Dis Colon Rectum. 2007; 50:168-75. Doi: 10.1007/s10350-006-0756-2.

107. Bosch S. L., Nagtegaal I. D. The Importance of the Pathologist's Rolein Assessment of the Quality of the Mesorectum. Curr Colorectal Cancer Rep. 2012; 8: 90-8. Doi: 10.1007/s11888-012-0124-7.

108. Hida J., Yasutomi M., Maruyama T., Fujimoto K., Uchida T., Okuno K. Lymph node metastases detected in the mesorectum distal to carcinoma of the rectum by the clearing method: justification of total mesorectal excision. J Am Coll Surg. 1997; 184:584-8.

109. Grüter A. A. J., van Lieshout A. S., van Oostendorp S. E., Ket J. C. F., Tenhagen M., den Boer FC, et al. Required distal mesorectal resection margin in partial mesorectal excision: a systematic review on distal mesorectal spread. Tech Coloproctol. 2022 doi: 10.1007/s10151-022-02690-1.

110. Scott N., Jackson P., al-Jaberi T., Dixon M. F., Quirke P., Finan P. J. Total mesorectal excision and local recurrence: a study of tumour spread in the mesorectum distal to rectal cancer. Br J Surg. 1995; 82:1031-3. Doi: 10.1002/bjs.1800820808.

111. Pollett W. G., Nicholls R. J. The relationship between the extent of distal clearance and survival and local recurrence rates after curative anterior resection for carcinoma of the rectum. Ann Surg. 1983; 198:159-63. Doi: 10.1097/00000658-198308000-00008.

112. Kuvshinoff B., Maghfoor I., Miedema B., Bryer M., Westgate S., Wilkes J., Ota D. Distal margin requirements after preoperative chemo-radiotherapy for distal rectal carcinomas: are < or = 1 cm distal margins sufficient? Ann Surg Oncol. 2001; 8:163-9. Doi: 10.1007/s10434-001-0163-9.

113. Bujko K., Rutkowski A., Chang G. J., Michalski W., Chmielik E., Kusnierz J. Is the 1-cm rule of distal bowel resection margin in rectal cancer based on clinical evidence? A systematic review. Ann Surg Oncol. 2012; 19:801-8. Doi: 10.1245/s10434-011-2035-2.

114. Manegold P., Taukert J., Neeff H., Fichtner-Feigl S, Thomusch O. The minimum distal resection margin in rectal cancer surgery and its impact on local recurrence - A retrospective cohort analysis. Int J Surg. 2019; 69:77-83. Doi: 10.1016/j.ijsu.2019.07.029.

115. Pahlman L., Bujko K., Rutkowski A., Michalski W. Altering the therapeutic paradigm towards a distal bowel margin of < 1 cm in patients with low-lying rectal cancer: a systematic review and commentary. Colorectal Dis. 2013; 15:e166-74. Doi: 10.1111/codi.12120.

116. Sun G., Ye X., Zheng K., Zhang H., Broens P., Trzpis M., et al. Measurement of distal intramural spread and the optimal distal resection by naked eyes after neoadjuvant radiation for rectal cancers. World J Surg Oncol. 2022; 20:296. Doi: 10.1186/s12957-022-02756-2.

117. Goldstein N. S., Soman A., Sacksner J. Disparate surgical margin lengths of colorectal resection specimens between in vivo and in vitro measurements: the effects of surgical resection and formalin fixation on organ shrinkage. Am J Clin Pathol. 1999; 111349-51. Doi: 10.1093/ajcp/ 111.3.349].

118. Klein M. F., Vogelsang R. P., Gögenur I. Circumferential Resection Margin After Laparoscopic and Open Rectal Resection: A Nationwide Propensity Score Matched Cohort Study. Dis Colon Rectum 2019; 62:1177-85. Doi:10.1097/DCR.0000000000001460.

119. Sung S., Kim S. H., Le J. H., Nam T. K., Jeong S., Jang H. S., et al. Continuous Effect of Radial Resection Margin on Recurrence and Survival in Rectal Cancer Patients Who Receive Preoperative Chemoradiation and Curative Surgery: A Multicenter Retrospective Analysis. Int J Radiat Oncol Biol Phys. 2017; 98:647-53. Doi: 10.1016/j.ijrobp.2017.03.008.

120. Glynne-Jóns R., Mawdsley S., Novell J. R. The clinical significance of the circumferential resection margin following preoperative pelvic chemo-radiotherapy in rectal cancer: why we need a common language. Colorectal Dis. 2006; 8:800-7. Doi: 10.1111/j.1463-1318.2006.01139.x.

121. den Dulk M., Marijnen C. A., Putter H., Rutten H. J., Beets G. L., Wiggers T., et al. Risk factors for adverse outcome in patients with rectal cancer treated with an abdominoperineal resection in the total mesorectal excision trial. Ann Surg. 2007; 246:83-90. Doi: 10.1097/01.sla.0000259432. 29056.9d.

122. den Dulk M., Putter H., Collette L., Marijnen C. A. M., Folkesson J., Bosset J. F., et al. The abdominoperineal resection itself is associated with an adverse outcome: the European experience based on a pooled analysis of five European randomised clinical trials on rectal cancer. Eur J Cancer. 2009; 45:1175-83. Doi: 10.1016/j.ejca.2008.11.039.

123. Reshef A., Lavery I., Kiran R. P. Factors associated with oncologic outcomes after abdominoperineal resection compared with restorative resection for low rectal cancer: patient-and tumor-related or technical factors only? Dis Colon Rectum. 2012; 55:51-8. Doi: 10.1097/DCR.0b013e3182351c1f.

124. Kim J. C., Yu C. S., Lim S. B., Kim C. W., Kim J. H., Kim T.W. Abdominoperineal resection and low anterior resection: comparison of long-term oncologic outcome in matched patients with lower rectal cancer. Int J Colorectal Dis. 2013; 28:493-501.doi: 10.1007/s00384-012-1590-8.

125. Wang X. T., Li D. G., Li L., Kong F. B., Pang L. M., Mai W. Meta-analysis of oncological outcome after abdominoperineal resection or low anterior resection for lower rectal cancer. Pathol Oncol Res. 2015; 21):19-27. Doi: 10.1007/s12253-014-9863-x.

126. Holm T., Ljung A., Häggmark T., Jurell G., Lagergren J. Extended abdominoperineal resection with gluteus maximus flap reconstrution of the pelvic floor for rectal cancer. Br J Surg. 2007; 94:232-8. Doi: 10.1002/bjs.5489.

127. West N. P., Anderin C., Smith K. J., Holm T., Quirke P. European Extralevator Abdominoperineal Excision Study Group. Multicentre experience with extralevator abdominoperineal excision for low rectal cancer. Br J Surg. 2010; 97:588-99. Doi: 10.1002/bjs.6916.

128. Chen E., Chi P. Meta-analysis of extralevator abdominoperineal excision for rectal cancer. Zhonghua Wei Chang Wai Ke Za Zhi. 2017; 20(3):326-332. Chinese.

129. Perdawood S. K., Lund T. Extralevator versus standard abdominoperineal excision for rectal cancer. Tech Coloproctol. 2015 Mar; 19(3):145-52. Doi: 10.1007/s10151-014-1243-8.

130. Ortiz H., Ciga M. A., Armendariz P., Kreisler E., Codina-Cazador A., Gómez Barbadillo J., García Granero E., Roig J. V., Biondo S. Spanish Rectal Cancer Project. Multicentre propensity score-matched analysis of conventional versus estendede abdominoperineal excision for low rectal cancer. Br J Surg. 2014 Jun; 101(7):874-82. Doi: 10.1002/bjs.9522.

131. Asplund D., Haglind E., Angenete E. Outcome of extralevator abdominoperineal excision compared with standard surgery: results from a single centre. Colorectal Dis. 2012; 14:1191-6. Doi: 10.1111/j.1463-1318.2012.02930.x.

132. Carpelan A., Karvonen J., Varpe P., Rantala A., Kaljonen A., Grönroos J., et al. Extralevator versus standard abdominoperineal excision in locally advanced rectal cancer: a retrospective study with long-term follow-up. Int J Colorectal Dis. 2018; 33:375-81. Doi: 10.1007/s00384-018-2977-e.

133. Bianco F., Romano G., Tsarkov P., Stanojevic G., Shroyer K., Giuratrabocchetta S., Bergamaschi R. International Rectal Cancer Study Group. Extralevator with vs. nonextralevator abdominoperineal excision for rectal cancer: the RELAPe randomized controlled trial. Colorectal Dis. 2017; 19:148-57. Doi: 10.1111/codi.13436.

134. Seshadri R. A., West N. P., Sundersingh S. A pilot randomized study comparing extralevator with conventional abdominoperineal excision for low rectal cancer after neoadjuvant chemoradiation. Colorectal Dis. 2017; 19: Ou253-Ou262. Doi: 10.1111/codi.13726.

135. Shen Z., Bu Z., Li A., Lu J., Zhu L., Chong C. S., et al. Multicenter study of surgical and oncologic outcomes of extra-levator versus conventional abdominoperineal excision for lower rectal cancer. Eur J Surg Oncol. 2020 J46:115-22. Doi: 10.1016/j.ejso.2019.08.017.

136. Habr-Gama A., São Julião G. P., Mattacheo A., de Campos Lobato L. F., Aleman E., Vailati B. B., Gama Rodrigues J., Pérez R. O. Extralevator Abdominal Perineal Excision Versus Standard Abdominal Perineal Excision: Impact on Quality of the Resected Specimen and Postoperative Morbidity. World J Surg. 2017 Aug; 41(8):2160-2167. Doi: 10.1007/s00268-017-3963-1.

137. Zhang H., Li G., Cao K., Zhai Z., Wei G., Ye C., Zhao B., Wang Z., Han J. Long-term outcomes after extra-levator versus conventional abdominoperineal excision for low rectal cancer. BMC Surg. 2022; 22:242. Doi: 10.1186/s12893-022-01692-e.

138. Qi X., Cui M., Liu M., Xu K., Tan F., Yao Z., et al. (2019). Extralevator abdominoperineal excision versus abdominoperineal excision for low rectal cancer. Chinese Medical Journal, 2019; 132: 2446-56. Doi: 10.1097/CM9.0000000000000485.

139. Molina Rodríguez J. L., Flor Lorente B., Frasson M., García Botello S., Esclápez P., Espí A., et al. Low rectal cancer: abdominoperineal resection or low Hartmann resection? A postoperative outcome analysis. Dis Colon Rectum. 2011; 54:958-62. Doi: 10.1097/DCR.0b013e31821c4b95.

140. Frye J. N., Carne P. W., Robertson G. M., Frizelle F. A. Abdominoperineal resection or low Hartmann's procedure. ANZ J Surg. 2004; 74:537-40. Doi: 10.1111/j.1445-2197.2004.03055.x.

141. Tøttrup A., Frost L. Pelvic sepse after estendede Hartmann's procedure. Dis Colon Rectum. 2005; 48:251-5. Doi: 10.1007/s10350-004-0767-9.

142. Sverrisson I., Nikberg M., Chabok A., Smedh K. Hartmann's procedure in rectal cancer: a population-based study of postoperative complications. Int J Colorectal Dis. 2015; 30:181-6. Doi: 10.1007/s00384-014-2069-6.

143. Sverrisson I., Nikberg M., Chabok A., Smedh K. Low risk of intra-abdominal infections in rectal cancer patients treated with Hartmann's procedure: a report from a national registry. Int J Colorectal Dis. 2018; 33:327-32. Doi: 10.1007/s00384-018-2967-0.

144. Westerduin E., Aukema T. S., van Geloven A. A. W., Bemelman W. A., Tanis P. J. Dutch Snapshot Research Group. What to do with the rectal stump during sphincter preserving rectal cancer resection with end colostomy: a collaborative snapshot study. Colorectal Dis. 2018; 20:696-703. Doi: 10.1111/codi.14100.

145. Popiolek M., Dehlaghi K., Gadan S., Baban B., Matthiessen P. Total Mesorectal Excision for Mid-Rectal Cancer Without Anastomosis: Low Hartmann's Operation or Intersphincteric Abdomino-Perineal Excision? Scand J Surg. 2019; 108:233-40. Doi: 10.1177/1457496918812219.

146. Ahmad N. Z., Azam M., Coffey J. C. A meta-analysis of low Hartmann's procedure versus abdominoperineal resection for non-restorative treatment of rectal cancer. Int J Colorectal Dis. 2021; 36:2585-98. Doi: 10.1007/s00384-021-03993-9.

147. Fowler H., Clifford R., Sutton P., Watson A., Fearnhead N., Bach S., et al. Hartmann's procedure versus intersphincteric abdominoperineal excision (HiP Study): a multicentre prospective cohort study. Colorectal Dis. 2020; 22:2114-22. Doi: 10.1111/codi.15366.

148. Choy K. T., Le D. J., Prabhakaran S., Warrier S., Heriot A., Kong J. C. The complication profile of low Hartmann's in rectal cancer: a systematic review and meta-analysis. ANZ J Surg. 2022. Doi: 10.1111/ans.17827.

149. Smedh K., Sverrisson I., Chabok A., Nikberg M. HAPIrect Collaborative Study Group. Hartmann's procedure vs. abdominoperineal resection with intersphincteric dissection in patients with rectal cancer: a randomized multicentre trial (HAPIrect). BMC Surg. 2016; 16:43. Doi: 10.1186/s12893-016-0161-2.

Descargas

Publicado

26-02-2026

Cómo citar

Prieto González, J., Torres García, M., & Paredes Cotoré , P. (2026). Resección local, resección radical y amputación abdominoperineal: Hartmann bajo versus amputación abdominoperineal interesfinteriana. Revista De Cirugía De Galicia, 10(14). Recuperado a partir de https://revista.proeditio.com/RevistaSociga/article/view/8920